Immunohistochemical Analysis of MMP-2 Expression in the Myocardium During the Postinfarction Period

Verfasser / Beitragende:
[L. Nepomnyashchikh, E. Lushnikova, M. Bakarev, D. Nikityuk, E. Yuzhik, M. Mzhelskaya, R. Nepomnyashchikh, M. Klinnikova, A. Karpova]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/4(2015-08-01), 505-510
Format:
Artikel (online)
ID: 605535841
LEADER caa a22 4500
001 605535841
003 CHVBK
005 20210128100849.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-3004-8  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-3004-8 
245 0 0 |a Immunohistochemical Analysis of MMP-2 Expression in the Myocardium During the Postinfarction Period  |h [Elektronische Daten]  |c [L. Nepomnyashchikh, E. Lushnikova, M. Bakarev, D. Nikityuk, E. Yuzhik, M. Mzhelskaya, R. Nepomnyashchikh, M. Klinnikova, A. Karpova] 
520 3 |a Immunohistochemical analysis revealed 2.5-fold increased of expression MMP-2 in myocardium samples during the early period (up to 3 days) of postinfarction reparative regeneration. During this period, MMP-2 was detected mainly in monocytes/macrophages circulating in the blood and migrating to the necrotic zone, while expression in the intermuscular and perivascular connective tissue was lower. At later terms, with development of large focal and diffuse cardiosclerosis, MMP-2 expression significantly decreased (to the initial level) and was detected mainly in the foci of intermuscular and perivascular fibrosis, its area in the sections increased by 1.8 times. Evaluation of MMP-2 expression in the blood vessels showed that the immunohistochemical reaction was the most pronounced in the walls of new sinusoidal vessels and the minimum in the intramural arteries of medium diameter. These results attest to an important role of MMP in connective tissue remodeling (proteolytic degradation) during the early period of postinfarction reparative regeneration. The decrease in MMP-2 expression observed at later terms correlated with myocardial fibrosis progression. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a myocardial infarction  |2 nationallicence 
690 7 |a cardiofi brosis  |2 nationallicence 
690 7 |a matrix metalloproteinase-2  |2 nationallicence 
690 7 |a immunohistochemistry  |2 nationallicence 
700 1 |a Nepomnyashchikh  |D L.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Lushnikova  |D E.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Bakarev  |D M.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Nikityuk  |D D.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Yuzhik  |D E.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Mzhelskaya  |D M.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Nepomnyashchikh  |D R.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Klinnikova  |D M.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
700 1 |a Karpova  |D A.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/4(2015-08-01), 505-510  |x 0007-4888  |q 159:4<505  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-3004-8  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-3004-8  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nepomnyashchikh  |D L.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lushnikova  |D E.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bakarev  |D M.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nikityuk  |D D.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yuzhik  |D E.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mzhelskaya  |D M.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nepomnyashchikh  |D R.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Klinnikova  |D M.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Karpova  |D A.  |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/4(2015-08-01), 505-510  |x 0007-4888  |q 159:4<505  |1 2015  |2 159  |o 10517